Intellia Therapeutics
NTLA
$20.76
Share price
3.70%
Change (1 day)
-42.79%
Change (1 year)
Intellia Therapeutics (NTLA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.25 B
According to Intellia Therapeutics's latest financial reports the company's total liabilities are $0.25 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Intellia Therapeutics - Total liabilities on balance sheet (from 2015 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | -11.85% |
| 2022-12-31 | $0.28 B | 11.92% |
| 2021-12-31 | $0.25 B | 70.33% |
| 2020-12-31 | $0.14 B | 131.76% |
| 2019-12-31 | $64.39 M | -7.2% |
| 2018-12-31 | $69.39 M | -8.25% |
| 2017-12-31 | $75.63 M | -15.14% |
| 2016-12-31 | $89.13 M | -13.75% |
| 2015-12-31 | $0.10 B | 3203.71% |
| 2014-12-31 | $3.12 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -88.87% | 🇺🇸 USA |